- Home
- PRDO vs TARS Comparison
PRDO vs TARS Comparison
Compare PRDO & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRDO
- TARS
- Stock Information
- Founded
- PRDO 1994
- TARS 2016
- Country
- PRDO United States
- TARS United States
- Employees
- PRDO N/A
- TARS N/A
- Industry
- PRDO Other Consumer Services
- TARS Medicinal Chemicals and Botanical Products
- Sector
- PRDO Real Estate
- TARS Health Care
- Exchange
- PRDO Nasdaq
- TARS Nasdaq
- Market Cap
- PRDO 2.1B
- TARS 1.7B
- IPO Year
- PRDO N/A
- TARS 2020
- Fundamental
- Price
- PRDO $32.92
- TARS $57.63
- Analyst Decision
- PRDO Buy
- TARS Strong Buy
- Analyst Count
- PRDO 1
- TARS 7
- Target Price
- PRDO $40.00
- TARS $67.14
- AVG Volume (30 Days)
- PRDO 584.7K
- TARS 630.9K
- Earning Date
- PRDO 07-31-2025
- TARS 08-06-2025
- Dividend Yield
- PRDO 1.83%
- TARS N/A
- EPS Growth
- PRDO 12.96
- TARS N/A
- EPS
- PRDO 2.30
- TARS N/A
- Revenue
- PRDO $768,844,000.00
- TARS $295,521,000.00
- Revenue This Year
- PRDO $25.27
- TARS $33,170.29
- Revenue Next Year
- PRDO $3.29
- TARS N/A
- P/E Ratio
- PRDO $14.29
- TARS N/A
- Revenue Growth
- PRDO 15.99
- TARS 254.45
- 52 Week Low
- PRDO $20.55
- TARS $27.18
- 52 Week High
- PRDO $34.60
- TARS $59.76
- Technical
- Relative Strength Index (RSI)
- PRDO 62.31
- TARS 69.92
- Support Level
- PRDO $32.49
- TARS $57.00
- Resistance Level
- PRDO $33.28
- TARS $59.76
- Average True Range (ATR)
- PRDO 0.63
- TARS 1.74
- MACD
- PRDO -0.03
- TARS -0.26
- Stochastic Oscillator
- PRDO 59.92
- TARS 67.78
About PRDO Perdoceo Education Corporation
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.